FBXW7 and breast cancer: This indicates that in FBXW7-deficient breast cancers, the NF-κB signaling pathway that should be subject to normal E3 ubiquitin ligase binding and degradation is blocked, leading to increased NF-κB DNA binding activity and promoting tumor growth and metastasis.